Categories: NewsPharmaceutical

Anju to Highlight Newly Launched MA Knowledge at DIA MICC 2024 in London

CHICAGO, Sept. 19, 2024 /PRNewswire/ — Anju, a leading provider of adaptive life sciences software solutions, is pleased to announce its participation as an exhibitor at the upcoming DIA Medical Information & Communications Conference scheduled to take place in London on September 24-25th. DIA MICC brings together medical information professionals for discussions, learning, and practical sessions around improving customer experiences across the industry.

Anju is proud to present MA Knowledge, a state-of-the-art application that offers access to verified and carefully curated medical information content, tailored to meet the unique needs of each field representative. With efficient content filtering and search features, MA Knowledge consistently delivers medical information that matches user profiles and their areas of interest.

“Anju’s commitment to innovation was the driving force behind the development of MA Knowledge,” said Reed McLaughlin, General Manager of Anju’s Medical Affairs Division. “We recognized an opportunity to vastly improve the field representatives’ customer experience by providing quick access to trustworthy, curated information.”

Attendees at DIA MICC 2024 are encouraged to visit Anju at booth 8 to explore their adaptable solutions and discuss how Anju’s best-in-class technology can help to streamline your medical information and scientific communications process. Anju’s team of experts will be on hand to answer questions and discuss how Anju’s solutions can meet the unique needs of your organization.

About Anju:
Anju Software is a customer-first organization providing adaptable life science solutions for clinical research, medical affairs, and data science. TrialMaster, IRMS MAX, and TA Scan, the company’s flagship products, lead the way in reducing complexities in the drug and device discovery and commercialization process. Anju is a portfolio company of Abry Partners serving the worldwide pharmaceutical, biotech and contract research Life Sciences markets.

For media inquiries, please contact:
John F. Kouten
JFK Communications, Inc.
+1 609.241.7352
jfkouten@jfkhealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/anju-to-highlight-newly-launched-ma-knowledge-at-dia-micc-2024-in-london-302253584.html

SOURCE Anju Software

Staff

Recent Posts

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

2 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

2 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

2 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

2 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

2 hours ago

PulseAI Secures Seed Funding to Advance AI-Driven ECG Diagnostics

BELFAST, Northern Ireland  , Jan. 12, 2026 /PRNewswire/ -- PulseAI, a rapidly emerging leader in…

2 hours ago